[ad_1]
Mayank Sen, a public relations officer at the Seram Institute, told the BBC’s Yogita Limayi in Delhi that the news of the ban on vaccine exports in an international media outlet “was not entirely accurate,” reported BBC Bangla. Monday.
BBC Bangla writes: “There is no ban on the export of vaccines. However, the company (Serum Institute) is now in the process of obtaining permission to export the vaccine to another country, which may take a few months.
However, before the start of exports, the Indian government agreed to provide 100 million vaccines (Serum Institute). But for the moment they will not be able to export because they cannot export ”.
Seram Institute to Meet Indian Demand Before Exporting Vaccines
Bangladesh ‘no problem’ with vaccines: Minister of Health
Beximco has no doubt that Bangladesh will receive the vaccine within the stipulated time.
The chancellor also said there was no fear of vaccination.
The coronavirus vaccine, jointly developed by the University of Oxford and AstraZeneca, is produced and marketed by the Serum Institute of India.
On November 5, the government of Bangladesh signed an agreement with the Seram Institute of India to purchase 30 million doses of the vaccine called Covishield. Under the agreement, the Seram Institute will ship 5 million doses of vaccine each month.
The Health Minister also said that the process of depositing 600 million Tk through the bank as an advance for those three crore dose vaccines has also started.
Beximco Pharmaceuticals Limited is responsible for importing vaccines from India and supplying them to Bangladesh. They are the “exclusive distributor” of vaccines produced at the Seram Institute in Bangladesh.
If the Indian pharmaceutical regulator approves the emergency use of Kovishield on Sunday, hopes for a rapid vaccine in Bangladesh have been raised, as the health minister has said that if India approves it, Bangladesh will receive its first shipment of Oxford vaccine in January.
But Adar Poonawala, executive director of the Seram Institute, was quoted in various international media outlets Sunday night as saying that they would insist on meeting local demand from India for the next two months before exports could begin.
Based on his statement, an international news agency reported that India had “banned” the export of vaccines. The news raised fears that vaccines in Bangladesh could be delayed.
However, Rabbur Reza, COO of Beximco Pharmaceuticals, told bdnews24.com that they had “no doubts” about the vaccine.
“According to our agreement with the Seram Institute, we will get the first batch of vaccines within a month after the vaccine is approved in Bangladesh.”
He said they had submitted documents to the Department of Drug Administration last Thursday for approval of Oxford-AstraZeneca’s Covishield vaccine, produced at the Serum Institute of India. On Monday they will request the approval of the ticker.
Coronavirus: Beximco signs an agreement with the Seram Institute of India for vaccination
Coronavirus: Agreement to import 30 million doses of vaccine from India
Meanwhile, the Minister of Health, Zahid Malek, and the Secretary of Health Services, after a meeting at the Secretariat of the coronavirus vaccine. Abdul Mannan also assured reporters about this.
The Health Minister said: “I have been working on this issue since morning. Discussions have been held with Beximco, the Ministry of Foreign Affairs and the Indian Mission. They assured that the agreement reached with us will not be affected. There will be no problem, we continue the discussion ”.
Under the agreement, the Seram Institute will vaccinate Bangladesh only if the WHO gives its permission, he said. This agreement is international, so we have confidence in it. We are optimistic about everything ”.
Asked when the first shipment of vaccines could arrive in Bangladesh, the Health Minister said: “The matter is being investigated, because yesterday there was no problem.” It cannot be said right now, I will be able to report in two or four days ”.
After waiting for approval, vaccination in India will start soon
The price of each dose of vaccine will be around Tk 425: Minister of Health
Bangladesh is giving an advance of Tk 600 crore for vaccination
Health Secretary. Abdul Mannan said: “I just called (at noon) the Deputy High Commissioners of India. He told us that the agreement we made, … his financial transaction, how the money will go, how the bank will give a guarantee, all those things have been done by GTZ or the government to the government. The ban that has been mentioned, the government of India has said only about business activities, not about us. Because ours is from government to government. “
Assuring that there is “no fear” about the vaccine, the secretary said: “The Seram Institute of India has received approval from the Government of India. Once approved, they will go to WHO for approval, which will take about three weeks. Our time was called pub in February. After these three weeks, that is, there is no time to delay. There is still nothing to worry about. The issue of sending money has been finalized today and is being sent. “
Foreign Minister AK Abdul Momen also tried to allay concerns by talking to journalists about the vaccine in the afternoon.
“We have received an update, the Indian Ministry of Foreign Affairs has informed us that the bilateral agreement that India has signed with us will be implemented,” he said.
“They said that since the decision on vaccination was of the highest level, the Honorable Prime Minister Sheikh Hasina had spoken with Indian Prime Minister Narendra Modi and it was done. So there will be no ban. There is no reason to worry about that. They said that Bangladesh should not worry. “
Kovid-19: the government will provide 30 million doses of vaccine at no cost
Oxford-AstraZeneca vaccine is 80% effective
[ad_2]
